TRANSFORM Alliance’s Post

🧬Why bring ATMP research, development and access issues to the EU agenda today? 🎙Hear what our Steering Group had to say on the need to tailor incoming EU legislation to the specificities of ATMPs. Martine Pergent from IPOPI - International Patient Organisation for Primary Immunodeficiencies and Giovanni Migliaccio from EPTRI joined us last month for the annual TRANSFORM MEP Interest Group Conference, alongside other patient, clinician, academic and industry representatives from the Alliance. 🇪🇺Multistakeholder dialogue is a core value for TRANSFORM and a key tool in the development of future-proof policy that can drive patient access to innovative therapies across the EU. ➡️Visit our website to read the full event report: https://lnkd.in/e5XfpZRH #MEPsforATMPs #EuropeanParliament #orphanmedicines #competitiveness #raredisease #cellandgene 

To view or add a comment, sign in

Explore topics